Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: Relationships with clinical malaria and with entomological inoculation rates

Parasite Immunology

Volumn 21, Issue 6, 1999, Pages 307-317

  Kitua, A Y ^a   Urassa, H ^a   Wechsler, M ^b   Smith, T ^b   Vounatsou, P ^b   Weiss, N A ^b   Alonso, P L ^c   Tanner, M ^b  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Antibody; CSP; Infants; Maternally acquired; Morbidity; MSP 1; P. falciparum malaria; Tanzania

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; MALARIA VACCINE;

AMINO TERMINAL SEQUENCE; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE TRANSMISSION; HUMAN; IMMUNOADSORPTION; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DOMAIN; RISK FACTOR;

AGING; ANIMALS; ANTIBODIES, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT; INFANT, NEWBORN; MALARIA VACCINES; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TANZANIA;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0033036991     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.1999.00230.x     Document Type: Article

References (54)

1. Alonso P.L., Lopez M.C., Bordmann G. et al.; (1998) Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children. Parasite Immunology 20, 63-70
2. Alonso P.L., Smith T., Armstrong Schellenberg J.R.M. et al. (1994) Randomised trial of efficacy of the SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344, 1175-1181
3. Al-Yaman F., Genton B., Anders R. et al. (1995) Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunology 9, 493-501
4. Baird J.K., Purnomo H.B., Bangs M.J. et al. (1993) Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. American Journal of Tropical Medicine and Hygiene 49, 707-719
5. Biggar R.J., Collins W.E. & Campbell C.C. (1980) The serological response to primary malaria infection in urban Ghanaian infants. American Journal of Tropical Medicine and Hygiene 29, 720-724
6. Blackman M.J., Heidrich H.G. & Donachie S. (1990) A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. Journal of Experimental Medicine 172, 379-382
7. Bouharoun-Tayoun H. & Druilhe P. (1992) Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infection and Immunity 60, 1473-1481
8. Bruce-Chwatt L. (1952) Malaria in African infants and children in Southern Nigeria. Annals of Tropical Medicine and Parasitology 46, 173-200
9. Charlwood J.D., Smith T., Lyimo E. et al. (1998) Incidence of Plasmodium falciparum infection in infants in relation to exposure to sporozoite infected anophelines. American Journal of Tropical Medicine and Hygiene 59, 243-251
10. Chizzolini C., Trottein F., Bernard F.X. et al. (1991) Isotypic analysis, antigen specificity, and inhibitory function of maternally transmitted Plasmodium falciparum-specific antibodies in Gabonese newborns. American Journal of Tropical Medicine and Hygiene 45, 57-64
11. Cohen S., McGregor I.A. & Carrington S.P. (1961) Gammaglobulin and acquired immunity to human malaria. Nature 192, 733-737
12. Colbourne M.J. & Edington G.M. (1954) Mortality from malaria in Accra. Journal of Tropical Medicine and Hygiene 57, 203-210
13. Del Guidice G., Engers H.D., Tougne C. et al. (1987) Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children. American Journal of Tropical Medicine and Hygiene 36, 203-212
14. Desowitz R.S., Elm J. & Alpers M.P. (1993) Plasmodium falciparum-specific immunoglobulin G (IgG), IgM, and IgE antibodies in paired maternal-cord sera from East Sepik Province, Papua New Guinea. Infection and Immunity 61, 988-993
15. Ding Z.-M., Christiano R.J., Roth J.A. et al. (1995) Malarial Circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cells. Journal of Biological Chemistry 270, 3667-3676
16. Edozian J.C., Gilles H.M. & Udeozo I.O.K. (1962) Adult and cord blood gammaglobulin and immunity to malaria in Nigerians. Lancet ii, 951-955
17. Egan A.F., Morris J., Barnish G. et al. (1996) Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19kD C-terminal fragment of merozoite surface antigen, PfMSP-I. Journal of Infections Diseases 173, 765-769
18. Etlinger H.M., Felix A.M., Gillessen D. et al. (1988) Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. Journal of Immunology 140, 626
19. Facer C.A. & Tanner M. (1997) Clinical trials of malaria vaccines: progress and prospects. Advances in Parasitology 39, 1-68
20. Garnham P.C.C. (1949) Malaria immunity in Africans: effects in infancy and early childhood. Annals of Tropical Medicine and Parasitology 43, 47-61
21. Greenwood B.M. (1974) Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet i, 435-436
22. Greenwood B.M., Bradley-Moore A.M., Palit A. & Bryceson A.D.M. (1972) Immunosuppression in children with malaria. Lancet, 165, 172
23. Hawking F. (1954) Milk diet, p-aminobenzoic acid, and malaria in rats and monkeys. British Medical Journal 1, 1201-1202
24. Hogh B., Marbiah N.T., Burghaus P.A. et al. (1995) Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk offection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic. Infection and Immunity 63, 4034-4038
25. Kabilan L., Troye-Blomberg M., Patarroyo M.E. et al. (1987) Regulation of the immune response in Plasmodium falciparum malaria. IV. T. cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro. Clinical and Experimental Immunology 68, 288-297
26. Kilombero Malaria Project (1992) The level of anti-sporozoite antibodies in a highly endemic malaria area and its relationship with exposure to mosquitoes. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 499-504
27. Kitua A.Y. (1996) Incidence of Plasmodium falciparum infection and disease among infants living in a rural area under intense and perennial malaria transmission. PhD Thesis, University of Basel, Switzerland
28. Kitua A.Y., Smith T., Alonso P.L. et al. (1996) Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission. Tropical Medicine and International Health 1, 475-484
29. Kitua A.Y., Smith T., Alonso P.L. et al. (1997) The role of low level Plasmodium falciparum parasitaemia in anaemia among infants living in an area of intense and perennial transmission. Tropical Medicine and International Health 2, 325-333
30. Kumar S., Yadava A., Keister D.B. et al. (1995) Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-I in Aotus monkeys. Molecular Medicine 3, 325
31. Lew A.M., Beck D.J. & Thomas L.M. (1990) A second region recognized by the protective monoclonal antibody SC10/66 in the precursor to the major merozoite surface antigen of Plasmodium Chabaudi/Adami. Molecular and Biochemical Parasitology 41, 289-292
32. Macdonald G. (1950) The analysis of malaria parasite rates in infants. Tropical Disease Bulletin 47, 915-937
33. Macgraith B.G., Deegan T. & Sherwood Jones E. (1952) Suppression of malaria, Plasmodium berghei, by milk. British Medical Journal ii, 1382-1384
34. Marsh K., Greenwood B.M. (1986) The immunopathology of malaria. In Clinics in Tropical Medicine and Communicable Diseases, ed. G.T. Strickland, pp. 91-125, W.B. Saunders, Philadelphia
35. McGregor I.A. (1964) The passive transfer of human malarial immunity. American Journal of Tropical Medicine and Hygiene 13, 237-239
36. McGregor I.A., Carrington S. & Cohen S. (1963) Treatment of East African P. falciparum malaria with West African human gammaglobulin. Transactions of the Royal Society of Tropical Medicine and Hygiene 50, 170-175
37. Pasvol G., Weatherall D.J. & Wilson R.J.M. (1977) Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum. Nature 270, 171-173
38. Patarroyo M.E., Amador R., Clavijo P. et al. (1988) A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 332, 158-161
39. Patin̄o J.A.G., Holder A.A., McBride J.S. et al. (1997) Antibodies that inhibit malaria morozoite surface protein-I processing and erythrocyte invasion are blocked by naturally acquired human antibodies. Journal of Experimental Medicine 186, 1689-1699
40. Pouvelle B., Spiegel R., Hsiao L., et al. (1991) Direct access to serum macromolecules by intraerythrocytic malaria parasites. Nature 353, 73-75
41. Rasheed F.N., Bulmer J.N., De Francisco A. et al. (1995) Relationships between maternal malaria and malarial immune responses in mothers and neonates. Parasite Immunology 17, 1-10
42. Rodriguez R., Moreno A., Guzman F. et al. (1990) Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 43, 339
43. Rosenberg Y.J. (1978) Autoimmune and polyclonal B-cell responses during murine malaria. Nature 274, 170-172
44. Sehgal V.M., Siddiqui W.A. & Alpers M.P. (1989) A seroepidemiological study to evaluate the role of passive maternal immunity to malaria in infants. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, S105-S106
45. Sempertegui F., Estrella B., Moscoso J. et al. (1994) Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in randomised double-blind placebo-controlled field trial in an endemic area of Ecuador. Vaccine 12, 337
46. Smith T., Charlwood J.D., Kitua A.Y. et al. (1998) Relationships of malaria morbidity with exposure to Plasmodium fulciparum in young children in a highly endemic area. American Journal of Tropical Medicine and Hygiene 59, 252-257
47. Snow R.W., Omumbo J.A., Lowe B. et al. (1997) Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349, 1650-1654
48. Tanner M., De Savigny D., Mayombana C. et al. (1991) Morbidity and mortality at Kilombero, Tanzania, 1982-1988. In Disease and Mortality in Sub-Saharan Africa Editors, ed. Feachem RG, Jamison DT, pp. 286-305, Oxford University Press, Oxford
49. Tanner M., Del Giudice G., Betschart B. et al. (1986) Malaria transmission and development of anti-sporozoite antibodies in a rural African community. Memorias Instituto Oswaldo Cruz 81 (Suppl. 2), 199-205
50. Trape J.-F. & Rogier C. (1996) Combatting malaria morbidity and mortality in tropical Africa by reducing transmission. Parasitology Today 12, 236-240
51. Valero M.V., Amador R., Aponte J.J. et al. (1996) Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia. Vaccine 15, 1466-1470
52. Valero M.V., Amador L.R., Galindo C. et al. (1993) Vaccination with SPf66, a chemically synthesized vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 341, 705-710
53. Venables W.N. & Ripley B.D. (1994) Modern Applied Statistics with S-Plus. Springer, New York
54. Williams A.I.O. & McFarlane H. (1970) Immunoglobulin levels, malarial antibody titres and placental parasitaemia in Nigerian mothers and neonates. British Journal of Medical Science 1, 369-376